Skip to main content
. 2020 Dec 24;51(2):289–301. doi: 10.1007/s40279-020-01379-5

Table 2.

Sport-specific all-cause, CVD and cancer pooled-SMR’s

Endurance sports Team sports Power sports
Number of athletes (%) SMR (95% CI) Heterogenous (Y/N) Bias (Y/N) Number of athletes (%) SMR (95% CI) Heterogenous (Y/N) Bias (Y/N) Number of athletes (%) SMR (95% CI) Heterogenous (Y/N) Bias (Y/N)
All-cause mortality 53,476 (38.4%) 0.65 (0.54–0.77) Y N 78,504 (56.4%) 0.68 (0.57–0.81) Y Y 2826 (2.0%) 1.04 (0.91–1.12) Y N
CVD mortality 50,788 (38.4%) 0.63 (0.44–0.91) Y N 65,078 (55.0%) 0.76 (0.64–0.92) Y N 1885 (1.6%) 1.10 (0.86–1.40) Y N
Cancer mortality 50,511 (38.8%) 0.73 (0.50–1.07) Y N 65,280 (53.3%) 0.73 (0.57–0.93) Y N 1185 (1.5%) 0.51 (0.35–0.75) N N

SMR standardised mortality ratio, CI confidence interval, Y yes, N no

All SMR’s in bold indicate a significant difference compared to the general population (p < 0.05). An analysis was deemed heterogeneous based on a combination of the I2 and Q statistics and if the p value was ≤ 0.05. An analysis was deemed not biased if the p value derived from the eggers test was ≥ 0.05. More detail can be found in the Supplementary Files Online